2008
Klisch K, Jeanrond E, Pang PC, Pich A, Schuler G, Dantzer V, Kowalewski M, Dell A.
A tetraantennary glycan with bisceting N-acetylglucosamine and the SDa antigen is the predominant N-glycan on bovine pregnancy-associated glycoproteins.
Glycobiology 2008;18(1);42-52
Stolz A, Haines N, Pich A, Irvine KD, Hokke CH, Deelder AM, Gerardy-Schahn R, Wuhrer M, Bakker H.
Distinct contributions of β4GalNAcTA and β4GalNAcTB to Drosophila glycosphingolipid biosynthesis.
Glococonj J 2008;25(2);167-175
Genth H, Dreger SC, Huelsenbeck J, Just I.
Clostridium difficile toxins: More than mere inhibitiorsof Rho proteins.
The International Journal of Biochemistry and Cell Biology 2008;40;592-597
Hoffmann A, Hofmann F, Just I, Lehnardt S, Hanisch UK, Brück W, Kettenmann H, Ahnert-Hilger G, Höltje M.
Inhibition of Rho-dependent pathways by Clostridium botulinum C3 protein induces a proinflammatory profile in microglia.
Glia 2008;56(11);1162-1175
Höltje M, Hofmann F, Lux R, Veh RW, Just I, Ahnert-Hilger G.
Glutamate uptake and release by astrocytes are enhanced Clostridium botulinum C3 protein.
J Biol Chem 2008;283(14);9289-9299
Gerhard R, Nottrott S, Schoentaube J, Tatge H, Olling A, Just I.
Glucosylation of Rho GTPases by Clostridium difficile Toxin A triggers apoptosis in intestinal epithelial cells.
J Med Microbiol 2008;57(6);765-770
Busche S, Descot A, Julien S, Genth H, Posern G.
Epithelial cell-cell contacts regulate SRF-mediated transcription via Rac-actin-MAL signalling.
J Cell Sci 2008;121(7);1025-1035
Halabi-Cabezon I, Huelsenbeck J, May M, Ladwein M, Rottner K, Just I, Genth H.
Prevention of the cythopathik effect induced by Clostridium difficile Toxin B by active Rac1.
FEBS Lett 2008;582(27);3751-3756
Kamanova J, Kofronova O, Masin J, Genth H, Vojtova J, Linhartova I, Benada O, Just I, Sebo P.
Adenylate cyclase toxin subverts phagocyte function by RhoA inhibiton and unproductive ruffling.
J Immunol 2008;181(8);5587-5597
Mützelburg MV, Hofmann F, Just I, Pich A.
Isobaric tags for relative and absolute quantitation coupled with 2D-LC-MALDI-MS/MS techniques enable the identification of biomarkers of C3 exoenzyme treated human neuroblastoma cell lines.
J Chromatogr B 2008
Neumann D, Kollewe C, Pich A, Cao P, Resch K, Martin MU.
Threonine 66 in the death domain of IRAK-1 is critical for interaction with signaling molecules but is not a target site for autophosphorylation.
J Leukoc Biol 2008;84(3);807-813
Tschernig T, Neumann D, Pich A, Dorsch M, Pabst R.
Experimental bronchial asthma - the strength of the species rat.
Curr Drug Targets 2008;9(6);466-469
Höltje M, Djalali S, Hofmann F, Münster-Wandowski A, Hendrix S, Boato, Dreger SC, Grosse G, Henneberger C, Grantyn R, Just I, Ahnert-Hilger G.
A 29-amino acid fragment of Clostridium botulinum C3 protein enhances neuronal outgrowth, connectivity and reinnervation.
FASEB J. 2009 Apr;23(4);1115-26;Epub 2008
Schulte-Baukloh H, Bigalke H, Miller K, Heine G, Pape D, Lehmann J, Knispel HH.
Botulinum neurotoxin type A in urology: antibodies as a cause of therapy failure.
Int J Urol 2008;15;407-415
Sander LE, Frank SP, Bolat S, Blank U, Galli T, Bigalke H, Bischoff SC, Lorentz A.
Vesicle associated membrane protein (VAMP)-7 and VAMP-8, but not VAMP-2 or VAMP-3, are required for activation-induced degranulation of mature human mast cells.
Eur J Immunol 2008;38;855-863
Kühnel TS, Schulte-Mattler W, Bigalke H, Wohlfarth K.
Treatment of habituel snoring with botulinum toxin: a pilot study.
Sleep Breath 2008;12;63-68